Motif Neurotech

About Motif Neurotech

Motif Neurotech develops miniature brain-computer interface implants that utilize wireless power and data transmission to stimulate brain networks associated with treatment-resistant depression. These implants provide a non-invasive outpatient solution for restoring healthy brain activity, enabling patients to manage their mental health from home.

```xml <problem> Treatment-resistant depression often requires invasive procedures or high doses of medication, presenting significant side effects and limited efficacy for many patients. Current therapeutic options often fail to precisely target and restore healthy brain activity, leaving a substantial unmet need for effective, accessible, and personalized interventions. </problem> <solution> Motif Neurotech is developing a miniature, wireless brain-computer interface (BCI) implant designed to stimulate targeted brain networks and restore healthy brain activity in individuals with treatment-resistant depression. The DOT device is cosmetically invisible, delivered via an outpatient procedure, and designed for at-home use, providing a less invasive alternative to traditional methods. By utilizing innovations in wireless power and data transmission, the implant offers precise tissue stimulation and diagnostic readings, enabling personalized and effective neuromodulation. The device aims to address the biological underpinnings of depression, offering a novel approach to mental health treatment that can be tailored to individual patient needs. </solution> <features> - Miniature BCI implant for targeted brain network stimulation - Wireless power and data transmission for minimally invasive operation - Outpatient procedure for device implantation - Designed for convenient at-home use - Magnetoelectric materials for efficient wireless energy transfer - Personalized neuromodulation to restore healthy brain activity </features> <target_audience> The primary target audience includes individuals with treatment-resistant depression who have not responded adequately to traditional therapies, as well as psychiatrists and medical professionals seeking innovative and effective treatment options for their patients. </target_audience> ```

What does Motif Neurotech do?

Motif Neurotech develops miniature brain-computer interface implants that utilize wireless power and data transmission to stimulate brain networks associated with treatment-resistant depression. These implants provide a non-invasive outpatient solution for restoring healthy brain activity, enabling patients to manage their mental health from home.

Where is Motif Neurotech located?

Motif Neurotech is based in Houston, United States.

When was Motif Neurotech founded?

Motif Neurotech was founded in 2022.

How much funding has Motif Neurotech raised?

Motif Neurotech has raised 21700000.

Location
Houston, United States
Founded
2022
Funding
21700000
Employees
30 employees
Major Investors
Arboretum Ventures
Looking for specific startups?
Try our free semantic startup search

Motif Neurotech

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Motif Neurotech develops miniature brain-computer interface implants that utilize wireless power and data transmission to stimulate brain networks associated with treatment-resistant depression. These implants provide a non-invasive outpatient solution for restoring healthy brain activity, enabling patients to manage their mental health from home.

motifneuro.tech7K+
cb
Crunchbase
Founded 2022 – Houston, United States

Funding

$

Estimated Funding

$21.7M+

Major Investors

Arboretum Ventures

Team (30+)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

Treatment-resistant depression often requires invasive procedures or high doses of medication, presenting significant side effects and limited efficacy for many patients. Current therapeutic options often fail to precisely target and restore healthy brain activity, leaving a substantial unmet need for effective, accessible, and personalized interventions.

Solution

Motif Neurotech is developing a miniature, wireless brain-computer interface (BCI) implant designed to stimulate targeted brain networks and restore healthy brain activity in individuals with treatment-resistant depression. The DOT device is cosmetically invisible, delivered via an outpatient procedure, and designed for at-home use, providing a less invasive alternative to traditional methods. By utilizing innovations in wireless power and data transmission, the implant offers precise tissue stimulation and diagnostic readings, enabling personalized and effective neuromodulation. The device aims to address the biological underpinnings of depression, offering a novel approach to mental health treatment that can be tailored to individual patient needs.

Features

Miniature BCI implant for targeted brain network stimulation

Wireless power and data transmission for minimally invasive operation

Outpatient procedure for device implantation

Designed for convenient at-home use

Magnetoelectric materials for efficient wireless energy transfer

Personalized neuromodulation to restore healthy brain activity

Target Audience

The primary target audience includes individuals with treatment-resistant depression who have not responded adequately to traditional therapies, as well as psychiatrists and medical professionals seeking innovative and effective treatment options for their patients.